ASP Isotopes Reveals 15.1% Stake in ENDRA Life Sciences and Revised Merger Terms
ASPI is trading near its 52-week low of $2.51 (13% above the low).
Summary
ASP Isotopes disclosed a 15.1% stake in ENDRA Life Sciences, along with October 1 amendments to the merger agreement and warrants, and its intention to exercise pre-funded warrants to vote at the upcoming Special Meeting.
Key Events · Ownership and Investor Activity · ASPI
-
15.1% Beneficial Ownership Disclosed
ASP Isotopes and LHE LNG Holdings jointly report 254,015 shares of ENDRA Life Sciences common stock, representing 15.1% of the 1,499,912 shares outstanding as of October 6, 2026.
-
October 1 Amendments to Merger and Warrants
The filing incorporates by reference Amendment No. 1 to the Merger Agreement, Amendment No. 1 to the Common Warrant, and Amendment No. 1 to the Pre-Funded Warrant, all dated October 1, 2026 — none of which were previously disclosed in the timeline.
-
Intent to Exercise Pre-Funded Warrants for Voting
LHE LNG intends to exercise 187,169 pre-funded warrants before the Special Meeting record date to vote those shares on merger proposals, converting economic exposure into voting power.
-
Merger Control Structure
Upon completion of the merger, ASP Isotopes is expected to hold 100% of Class B super-voting shares (10 votes each) and approximately 26.2% of Class A shares, giving it roughly 98.9% of combined voting power.
Analysis · ASPI · Industrial Applications And Services
A joint Schedule 13D filed by ASP Isotopes and its subsidiary LHE LNG Holdings discloses beneficial ownership of 254,015 shares of ENDRA Life Sciences common stock, equal to 15.1% of the class. The filing brings to light three previously undisclosed amendments dated October 1, 2026 — covering the merger agreement, the common warrant, and the pre-funded warrant — and confirms LHE LNG's plan to exercise 187,169 pre-funded warrants before the Special Meeting record date to vote on the merger. With the merger set to hand ASP Isotopes roughly 98.9% of the combined company's voting power through Class B super-voting shares, this disclosure is pivotal for governance and control ahead of the shareholder vote.
How filings like this one have moved
In the 30 days to Oct 8, 2026, 28.6% of the 1679 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ASPI was trading at $2.83 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $433.9M. The 52-week trading range was $2.51 to $14.49. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.